Aegis Sciences Corporation Executive and Leadership Team

Donald Standridge, the Chief Executive Officer & Co-Founder at Aegis Sciences Corporation, directs the overarching strategic vision and operational framework for the forensic toxicology and healthcare sciences laboratory. Standridge guides the company's expansion initiatives, ensuring alignment with its founding mission of providing accurate and reliable scientific analysis. Overseeing all major corporate decisions, Donald Standridge drives innovation in diagnostic methodologies and laboratory services. This leadership role involves fostering a culture of scientific excellence and ethical practice across all departments. By championing advancements in forensic science, Standridge ensures Aegis Sciences Corporation maintains its position as a leader in the industry, supporting critical healthcare and legal processes through unparalleled analytical expertise.

David Priestley, the Chief Financial Officer at Aegis Sciences Corporation, directs the financial strategy and fiscal health of the forensic toxicology and healthcare sciences laboratory. Priestley oversees all financial planning, budgeting, and reporting activities, ensuring robust financial controls and compliance with industry regulations. This executive manages investment strategies and capital allocation to support the company's ongoing research and development efforts and operational expansion. David Priestley plays a crucial part in evaluating new business opportunities and ensuring the financial viability of all corporate initiatives. By maintaining strong financial discipline, Priestley enables Aegis Sciences Corporation to invest in cutting-edge technology and talent, solidifying its market position and long-term sustainability in the competitive healthcare sciences sector.

Beverly Cawthon, the Chief Operating Officer at Aegis Sciences Corporation, manages the day-to-day operational execution and efficiency of the forensic toxicology and healthcare sciences laboratory. Cawthon oversees the laboratory's complex workflows, ensuring seamless integration of advanced analytical technologies and stringent quality control measures. This executive directs the optimization of resource allocation and operational processes to support the company's growth and service delivery. Beverly Cawthon ensures that all laboratory functions adhere to the highest standards of scientific integrity and regulatory compliance, critical for the company's reputation and client trust. By focusing on operational excellence, Cawthon directly contributes to Aegis Sciences Corporation's capacity to deliver timely and accurate diagnostic results, underpinning the company's commitment to advancing healthcare sciences.

Joel Galanter, the Chief Legal Officer & General Counsel at Aegis Sciences Corporation, provides strategic legal counsel and oversees all legal affairs for the forensic toxicology and healthcare sciences laboratory. Galanter manages corporate governance, regulatory compliance, and risk management, ensuring adherence to all applicable laws and industry standards. This executive directs the legal framework supporting the company's operations, client agreements, and intellectual property protection. Joel Galanter ensures that Aegis Sciences Corporation navigates the complex legal landscape of healthcare and diagnostics with integrity and foresight. By safeguarding the company's legal interests, Galanter supports the consistent delivery of high-quality scientific services and reinforces the trust placed in Aegis Sciences Corporation by its clients and partners.